Questor Pharmaceuticals Stock Plummet Causes Shareholder Investigation by Goldfarb LLP Securities La
Questor Pharmaceuticals Stock Plummet Causes Shareholder Investigation by Goldfarb LLP Securities Lawyers
DALLAS--(BUSINESS WIRE)-- Securities lawyers at Goldfarb LLP are investigating alleged violations of shareholder protection laws by officers and directors of Questor Pharmaceuticals. (NAS: QCOR) in connection with an announcement that the Company was under government investigation. Concerned QCOR investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or email@example.com about their rights and remedies.
"Questor Pharmaceuticals stock plummeted to $18.81 per share after it admitted that the US Government was investigating its promotional practices," said Hamilton Lindley. "On September 19, Aetna announced that it would only reimburse coverage for only one type of treatment instead of the previous eighteen."
Goldfarb LLP has significant experience representing shareholders in securities lawsuits nationwide. QCOR stockholders - or anyone with knowledge about this situation - should contact lawyer Hamilton Lindley at firstname.lastname@example.org or 877-583-2855 with questions or concerns.
Hamilton Lindley, 214-583-2233
Toll Free Telephone: 877-583-2855
Fax Number: 214-583-2234
KEYWORDS: United States North America Texas
The article Questor Pharmaceuticals Stock Plummet Causes Shareholder Investigation by Goldfarb LLP Securities Lawyers originally appeared on Fool.com.Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.